LakeShore Biopharma
(NASDAQ) YS
LakeShore Biopharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$577.33M
Net Income (TTM)
$436.09M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
YS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout LakeShore Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
573
CEO
Xu Wang
Website
www.lakeshorebio.comHeadquarters
Beijing, 102600, CN
YS Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
-14%
Net Income Margin
-16%
Return on Equity
-18%
Return on Capital
-16%
Return on Assets
-7%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$507.19M
Operating Income
$86.29M
EBITDA
$48.54M
Operating Cash Flow
$120.98M
Capital Expenditure
$17.86M
Free Cash Flow
$138.84M
Cash & ST Invst.
$28.08M
Total Debt
$414.40M
LakeShore Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$135.53M
+27.7%
Gross Profit
$34.41M
-59.5%
Gross Margin
25.39%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
773
N/A
Net Income
$181.41M
-63.3%
EBITDA
$82.62M
-48.4%
Quarterly Fundamentals
Net Cash
$386.32M
-31.3%
Accounts Receivable
$501.79M
+16.9%
Inventory
$227.59M
+6.9%
Long Term Debt
$23.50M
-93.6%
Short Term Debt
$390.90M
+1200.5%
Return on Assets
-7.31%
N/A
Return on Invested Capital
-15.89%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A